Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Paul Hideo Opgenorth is Vice President, Development at Exozymes. OQRO lists 1 transaction filed with the SEC under this name, the latest on Apr 8, 2026, each linked to the official Form 4.
Vice President, Development
Disclosures on record
1
Companies involved
1
As of the latest filing on , Paul Hideo Opgenorth reported holding 645,149 shares of Exozymes (EXOZ), worth about $2.47M at the last close of $4 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Exozymes EXOZ | 645,149 | 645K direct | $4 | $2.47M | Apr 1, 2026 |
Is this Paul Hideo Opgenorth’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
ExozymesEXOZ
Apr 1, 20263,999disclosed Apr 8
DetailsOfficial recordOn the latest SEC Form 4, dated Apr 1, 2026, Paul Hideo Opgenorth reported holding 645,149 shares of Exozymes (EXOZ). At the last close of $4 on Nov 13, 2026, that is about $2.47M. This is the stake disclosed in filings, not a net worth.